iCubed Co-Director Denice Spero to Speak at 63rd Annual Clinical Laboratory Science Convention in Providence
Providence, R.I. — March 21, 2011 — Research Professor and iCubed Co-Director Dr. Denice Spero will be one of the featured speakers at the 63rd Annual Clinical Laboratory Science Convention taking place on May 3-5 at the Rhode Island Convention Center. Dr. Spero’s presentation will be “Genes to Vaccines: Accelerating Vaccine Discovery”. For more information on the event, please click here.
New Study from Rhode Island Hospital Identifies a Potential Vaccine to Prevent Gastritis, Ulcer Disease, Gastric Cancer
Providence, R.I. — March 10, 2011 – A new study led by researchers at Rhode Island Hospital in collaboration with the University of Rhode Island (URI) and EpiVax. Inc, a privately owned vaccine development company in Providence, RI, has identified a potential vaccine capable of reducing colonization of Helicobacter pylori (H. pylori) — a known cause of gastritis, ulcer disease and cancer. Their findings appear online in advance of print in the journal Vaccine. (Read more)
URI selects fellows for NTD vaccine design and training workshop
Providence, R.I. — December 3, 2010 – Next month the University of Rhode Island’s Institute for Immunology and Informatics will begin a workshop and training course aimed at targeting neglected tropical diseases. The workshop will focus on training NTD researchers interested in using new vaccine design tools developed by Principal Investigator and URI Professor Annie De Groot and Co-Investigator Bill Martin of Epivax Inc. (Read more)
Smart Vaccines course plants seeds for a biotech cluster in Providence
Providence, R.I. — November 1, 2010 — While plans to establish a video-gaming cluster of businesses in Providence have grabbed recent headlines, significant steps are being taken to develop another industry, focused on biotechnology, in the city’s nascent Knowledge District. (Read more)
From bouncer to biotechnology lab manager
KINGSTON, R.I. – October 27, 2010 – How many people can break a leg and look back on the experience as a blessing in disguise? Meet Joseph “Joe” Desrosiers once a bouncer, now a biotechnology lab manager. This fall, the 32-year-old added a new description to his list of growing achievements: homeowner. (Read more)
I’Cubed Co-Director Denice Spero sits down with the Providence Business News
Providence, R.I. – September 15, 2010 – Denice Spero, research professor and co-director of the University of Rhode Island’s Institute for Immunology and Informatics (I’Cubed), recently created an unheard-of class: “Smart Vaccines for Entrepreneurs,” forging a business/science curriculum for 14 students looking to explore business opportunities in the biotechnology field. (Read more)
Denice Spero, Ph.D., I’Cubed Co-Director, leads successful
Vaccine Entrepreneurship Program – June 20th, 2010
The 2010 Translational Immunology Research and Accelerated Vaccine Development (TRIAD) Toolkit
The 2010 TRIAD Toolkit Conference, hosted by the Institute for Immunology and Informatics at the University of Rhode Island, was a two-day gathering that provided an opportunity for researchers from a variety of disciplines to collaborate and critique each other’s research, and to familiarize themselves with iVAX, a leading software toolkit that allows researchers to reliably and efficiently make predictions in silico. A host of researchers from around New England, other parts of the United States and distant continents participated in the exchange of knowledge and the progression of science, addressing the application of informatics tools to topics ranging tick vaccines to the investigation of feline immunodeficiency virus as a model for HIV. (Read full article)
URI wins $13-million federal grant for vaccine research
Providence, R.I. — July 29, 2009 — Dr. Annie De Groot and her colleagues think they have a better way of speeding the development of vaccines against Lyme disease, hepatitis and stomach cancer. The federal government apparently believes their ideas are worth a $13-million investment. (Read more)
URI’s De Groot wins $13M NIH grant
Providence, R.I. — July 28, 2009 – Prominent local researcher and University of Rhode Island professor Dr. Anne S. De Groot has been awarded a $13 million research grant from the National Institutes of Health. It is the second large NIH grant awarded to URI researchers in recent months. In May, a pharmacy professor received an $18 million award. (Read more)
Vaccine research has helped her make a difference
Providence, R.I. — June 1, 2009 – Dr. Anne S. De Groot went to medical school, she said, “to right the wrongs that had been wrought” in women’s health care. She planned to work in obstetrics and gynecology, but was angered by the attitudes of many men in her specialty. Then, in Africa, she found a new calling. (Read more)
